[go: up one dir, main page]

El-Essawy, 2005 - Google Patents

Synthesis of novel acyclonucleosides analogs of pyridothienopyrimidine as antiviral agents

El-Essawy, 2005

Document ID
14519311153537871890
Author
El-Essawy F
Publication year
Publication venue
Nucleosides, Nucleotides, and Nucleic Acids

External Links

Snippet

Nucleoside analogs of pyridothienopyramidines were prepared by condensing the sodium salt 2a, b with an acyclic side chain in the form of acetylated haloalkoxyalcohol, and subsequent removal of the protecting acetyl group in ammonia/methanol afforded 4a, b. The …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulfur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulfur or nitrogen atom directly attached in position 2 or 6, but not in both
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Similar Documents

Publication Publication Date Title
Baraldi et al. Design, synthesis, and biological evaluation of a second generation of pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidines as potent and selective A2A adenosine receptor antagonists
Liu et al. Size-expanded analogues of dG and dC: synthesis and pairing properties in DNA
US6320035B1 (en) C-nucleoside derivatives and their use in the detection of nucleic acids
Gomtsyan et al. Design, synthesis, and structure− activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors
EP1066266B1 (en) Cyclin dependent kinase inhibitors
DE19509038A1 (en) C-nucleoside derivatives and their use in the detection of nucleic acids
Renau et al. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4-and 4, 6-substituents on the antiviral activity of pyrrolo [2, 3-d] pyrimidines
US6403786B1 (en) Heterocyclic compounds and their use for isolating nucleic acids
Saxena et al. Synthesis and antiviral activity of certain 4-substituted and 2, 4-disubstituted 7-[(2-hydroxyethoxy) methyl] pyrrolo [2, 3-d] pyrimidines
Chang et al. 2, 6, 8-trisubstituted 1-deazapurines as adenosine receptor antagonists
West et al. 2-Alkyl (aryl)-and 2, 7-Dimethyl-4-substituted Aminopyrrolo [2, 3-d] pyrimidines
Gheidari et al. The quinazoline-2, 4 (1H, 3H)-diones skeleton: A key intermediate in drug synthesis
Rao et al. Fluorescent Charge-Neutral Analogue of Xanthosine: Synthesis of a 2 ‘-Deoxyribonucleoside Bearing a 5-Aza-7-deazaxanthine Base
El-Essawy Synthesis of novel acyclonucleosides analogs of pyridothienopyrimidine as antiviral agents
Tumir et al. Interactions of novel phenanthridinium–nucleobase conjugates with complementary and non‐complementary nucleotides in aqueous media
Goodenough et al. Site Specific Synthesis and Polymerase Bypass of Oligonucleotides Containing a 6-Hydroxy-3, 5, 6, 7-tetrahydro-9 H-imidazo [1, 2-a] purin-9-one Base, an Intermediate in the Formation of 1, N 2-Etheno-2 ‘-deoxyguanosine
Luo et al. Synthesis of 3-methylthio-1-phenyl-pyrazolo [3, 4-d][1, 2, 4] triazolo [1, 5-a] pyrimidin-4-one derivatives via tandem aza-Wittig reaction
Azab Utility of the enaminonitrile moiety in the synthesis of some biologically active thienopyrimidine derivatives
Moukha-Chafiq et al. SYNTHESIS AND BIOLOGICAL ACTIVITY OF 4-SUBSTITUTED 1-[1-(2-HYDROXYETHOXY)-METHYL-1, 2, 3-TRIAZOL-(4 & 5)-YLMETHYL]-1 H-PYRAZOLO [3, 4-d] PYRIMIDINES
WO2022065413A1 (en) Novel artificial nucleic acid, method for producing same, and use thereof
Seela et al. Pyrazolo [3, 4-d][1, 2, 3] triazine DNA: Synthesis and Base Pairing of 7-Deaza-2, 8-diaza-2 ‘-deoxyadenosine
Crespo et al. Exploring the influence of the substituent at position 4 in a series of 3, 4-dihydropyrimidin-2 (1 H)-one A 2B adenosine receptor antagonists
Lougiakis et al. Synthesis and antiviral activity evaluation of some novel acyclic C-nucleosides
El-Gazzar et al. Synthesis and Preliminary Antimicrobial Activity of New Pyrimido [4, 5-b]-quinoline and Pyrido [2, 3-d] pyrimidine
El-Essawy Synthesis of New Pyrido [2′, 3′: 3, 4] pyrazolo [1, 5-a] pyrimidines and Their Use in the Preparation of Tetraheterocyclic Systems